⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

KNSA News

Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares

Kiniksa Pharmaceuticals Announces U.S. Orphan Drug Designation for KPL-387 for the Treatment of Pericarditis